Such a dysregulation may be occurring in autoimmune diseases associated with pathogenic Th17 cells, such as Crohn’s disease, T1D, and multiple sclerosis69–71, or in Gimap5-associated diseases such as SLE, T1D, and allergic asthma1–4. Here, GIMAP5 is linked to type 1 diabetes mellitus.